Connect with us
A study in Nature Mental Health reveals a genetic link between ADHD and cannabis use disorder (CUD). Researchers found 36 overlapping genetic loci, particularly affecting impulse...
Poland's cannabis decriminalization debate is gaining momentum, with 73% public support. The Sejm Petitions Committee issued a desideratum to PM Donald Tusk, but bureaucratic delays slow...
The Netherlands’ "tolerance policy" allows legal cannabis sales in coffee shops but bans large-scale cultivation, forcing reliance on black-market suppliers. A study revealed contaminants like lead,...
Spain's Ministry of Health is advancing conservative medicinal cannabis regulations as a last-resort treatment for select conditions. A Royal Decree draft awaits EU approval before proceeding...
Spain's medical cannabis production grew 42.5% in 2024, reaching 51.3 tons, despite lacking domestic regulation. Licensed for export, the sector generates €500 million annually, driven by...
Cannabis legalization in the U.S. is linked to reduced benzodiazepine prescriptions, as a study in JAMA Network Open shows patients opt for cannabis to manage anxiety...
Philip Morris partners with Avicanna, leveraging Canada’s regulated cannabis market to expand into medical cannabis. Unlike competitors targeting recreational cannabis, PMI emphasizes patient care, research, and...
Cannabis use among youth is rising globally, driven by increased legalization. Early use, before age 16, disrupts brain development, impairing memory, decision-making, and reward processing. It...
Studies confirm cannabis legalization decreases youth use. In Colorado, teen cannabis use dropped 35% since 2012. Washington saw declines of 58%–61% among students. National data mirrors...
Israel, a global cannabis industry leader, faces a severe market crisis. In 2024, active cannabis companies dropped from 52 to 47, and available products fell from...